# Gefitinib

## Iressa 250mg

##### 臨採

| 藥品代碼   | OIRE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Treatment of patients with locally advanced or metastatic adenocarcinoma of the lung who have previously received chemotherapy.                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | 250 mg orally once daily with or without food.                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 禁忌       | Patients with known severe hypersensitivity to gefinitib or to any of the excipients of Iressa.                                                                                                                                                                                                                                                                                                                                                                                               |
| 副作用     | Diarrhoea， nausea， skin rash， dry skin， vomiting， anorexia， stomatitis， liver function abnormalities， nail disorder， alopecia， asthenia， conjunctivitis & blepharitis. Dermatologic: Acne (25% to 33% )， Dry skin (13% to 26% )， Pruritus (8% to 9% )， Rash (43% to 54% ) Endocrine metabolic: Weight loss (3% to 5% ) Gastrointestinal: Diarrhea (48% to 67% )， Loss of appetite (7% to 10% )， Nausea (13% to 18% )， Vomiting (9% to 12% ) Neurologic: Asthenia (4% to 6% ) |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                          |

